SPONSOR
Institut Curie
Total Trials
6
Recruiting
6
Phases
N/A
Conditions studied: Bronchopulmonary DiseaseDiagnoses DiseaseSkin DiseasesMetastatic Lung CancerTriple Negative Breast CancerCANCERCarcinoma, Pancreatic DuctalPrognosis
Institut Curie is a clinical research sponsor with 6 registered studies on ClinicalTrials.gov, of which 6 are actively recruiting participants. Research covers conditions including Bronchopulmonary Disease, Diagnoses Disease, Skin Diseases, Metastatic Lung Cancer.
Studies span multiple clinical phases, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Institut Curie
How many clinical trials has Institut Curie sponsored?
ClinicalMetric currently tracks 6 clinical trials sponsored by Institut Curie, of which 6 are actively recruiting participants. These trials cover conditions including Bronchopulmonary Disease, Diagnoses Disease, Skin Diseases. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Institut Curie research focus on?
Institut Curie clinical trials span Bronchopulmonary Disease, Diagnoses Disease, Skin Diseases, Metastatic Lung Cancer, Triple Negative Breast Cancer, and additional conditions. Sponsor focus areas evolve as trials complete and new programs launch.
How do I participate in a Institut Curie clinical trial?
To participate in a Institut Curie trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Institut Curie trials with current recruitment status updated daily.
Clinical Trials by Institut Curie
NCT06439901
Recruiting
Optimizing Bronchopulmonary Cancer Screening
Bronchopulmonary Disease
NCT07158879
Recruiting
Skin Reactions Related to Thoracic Implantable Chamber Dressings
Skin Diseases
NCT04790682
Recruiting
LIquid Biopsy to prEdict Responses To First-line immunotherapY in Metastatic Non-small Cell LUNG Cancer. LIBERTY LUNG
Metastatic Lung Cancer
NCT06225505
Recruiting
Early Detection of Triple Negative Breast Cancer Relapse (CUPCAKE)
Triple Negative Breast Cancer
NCT05441163
Recruiting
ProActIF-01 Trial: Feasibility Study of an Individualized Program of Nutrition and Adapted Physical Activity in Frail Patients With Advanced Digestive Cancers
CANCER
NCT05475366
Recruiting
Personalized First-line Chemotherapy Choice in Advanced Pancreatic Adenocarcinoma Using Transcriptomic Signatures
Carcinoma, Pancreatic Ductal
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology